Published in Lancet on January 03, 2009
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 35.92
Knowledge, attitude and practice of antibiotics: a questionnaire study among 2500 Chinese students. BMC Med Educ (2013) 1.20
Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage. Antimicrob Agents Chemother (2012) 1.01
New metallo β-lactamase NDM-1. Indian J Med Res (2010) 1.00
Legislation of clinical antibiotic use in China. Lancet Infect Dis (2013) 0.99
EnzyBase: a novel database for enzybiotic studies. BMC Microbiol (2012) 0.88
Acinetobacter calcoaceticus from a fatal case of pneumonia harboring bla(NDM-1) on a widely distributed plasmid. BMC Infect Dis (2015) 0.86
Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health. BMC Microbiol (2017) 0.83
The global challenge of antimicrobial resistance: insights from economic analysis. Int J Environ Res Public Health (2010) 0.83
Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health. PLoS One (2014) 0.83
What's new in multidrug-resistant pathogens in the ICU? Ann Intensive Care (2016) 0.83
Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients. PLoS One (2014) 0.77
Antibiotic use in rural China: a cross-sectional survey of knowledge, attitudes and self-reported practices among caregivers in Shandong province. BMC Infect Dis (2015) 0.77
Evaluation of Outpatient Antibiotic Use in Beijing General Hospitals in 2015. Chin Med J (Engl) (2017) 0.75
Do outcomes of acupuncture for back pain differ according to varying sociocultural contexts? The view from China. J Altern Complement Med (2012) 0.75
Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer. BMC Cancer (2015) 0.75
Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis (2016) 0.75
Building bridges to operationalise one health - A Sino-Swedish collaboration to tackle antibiotic resistance. One Health (2016) 0.75
Emergence and control of infectious diseases in China. Lancet (2008) 5.93
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49
A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis (2002) 4.61
Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother (2007) 3.44
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother (2005) 2.50
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother (2010) 2.43
Diarrhoea case management in low- and middle-income countries--an unfinished agenda. Bull World Health Organ (2007) 2.40
Can community health workers and caretakers recognise pneumonia in children? Experiences from western Uganda. Trans R Soc Trop Med Hyg (2006) 2.26
Meeting the challenge of antibiotic resistance. BMJ (2008) 2.21
Local fever illness classifications: implications for home management of malaria strategies. Trop Med Int Health (2004) 2.03
Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania. PLoS One (2011) 1.98
Tissue concentrations: do we ever learn? J Antimicrob Chemother (2007) 1.92
The primacy of public health considerations in defining poor quality medicines. PLoS Med (2011) 1.91
Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother (2012) 1.88
National campaigns to improve antibiotic use. Eur J Clin Pharmacol (2006) 1.84
Socioeconomic status overrides age and gender in determining health-seeking behaviour in rural Bangladesh. Bull World Health Organ (2005) 1.82
Antibiotic resistance--problems, progress, and prospects. N Engl J Med (2014) 1.80
Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett (2008) 1.71
Home-based management of fever in rural Uganda: community perceptions and provider opinions. Malar J (2007) 1.67
3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ (2012) 1.64
Community effectiveness of malaria treatment in Uganda--a long way to Abuja targets. Ann Trop Paediatr (2005) 1.62
Tackling antibiotic resistance. BMJ (2010) 1.60
Expanded Quality Management Using Information Power (EQUIP): protocol for a quasi-experimental study to improve maternal and newborn health in Tanzania and Uganda. Implement Sci (2014) 1.59
Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis (2013) 1.56
Community referral in home management of malaria in western Uganda: a case series study. BMC Int Health Hum Rights (2006) 1.55
Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat (2011) 1.47
Protein binding: do we ever learn? Antimicrob Agents Chemother (2011) 1.46
Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli. J Antimicrob Chemother (2005) 1.45
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat (2011) 1.40
Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. J Antimicrob Chemother (2006) 1.39
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community. Trop Med Int Health (2005) 1.39
Targeted intervention for the ultra poor in rural Bangladesh: Does it make any difference in their health-seeking behaviour? Soc Sci Med (2006) 1.39
Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS. J Pharm Biomed Anal (2008) 1.38
Predictors of survival in children with methymalonic acidemia with homocystinuria in Beijing, China: a prospective cohort study. Indian Pediatr (2015) 1.38
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments. Antimicrob Agents Chemother (2006) 1.36
Opt-out HIV testing during antenatal care: experiences of pregnant women in rural Uganda. Health Policy Plan (2011) 1.35
"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in Iran. Health Res Policy Syst (2010) 1.30
Theory and practice--a case study of coordination and ownership in the Bangladesh health SWAp. Health Res Policy Syst (2006) 1.29
A framework for global surveillance of antibiotic resistance. Drug Resist Updat (2011) 1.29
Local illness concepts--implications for management of childhood pneumonia in eastern Uganda. Acta Trop (2007) 1.29
Community acceptability and adoption of integrated community case management in Uganda. Am J Trop Med Hyg (2012) 1.25
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. Int J Antimicrob Agents (2002) 1.24
The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy Plan (2005) 1.22
Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis (2002) 1.20
Modifiable socio-behavioural factors associated with overweight and hypertension among persons aged 35 to 60 years in eastern Uganda. PLoS One (2012) 1.17
Home and community management of acute respiratory infections in children in eight Ugandan districts. Ann Trop Paediatr (2005) 1.16
Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis (2007) 1.15
The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharm World Sci (2004) 1.14
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. Antimicrob Agents Chemother (2011) 1.12
Effectiveness of feedback for improving case management of malaria, diarrhoea and pneumonia--a randomized controlled trial at provincial hospitals in Lao PDR. Trop Med Int Health (2003) 1.12
The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol Sci (2010) 1.12
Process and effects of a community intervention on malaria in rural Burkina Faso: randomized controlled trial. Malar J (2008) 1.07
'How to know what you need to do': a cross-country comparison of maternal health guidelines in Burkina Faso, Ghana and Tanzania. Implement Sci (2012) 1.06
Whose job is it anyway? Swedish general practitioners' perception of their responsibility for the patient's drug list. Ann Fam Med (2010) 1.06
Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J Antimicrob Chemother (2003) 1.06
High compliance with newborn community-to-facility referral in eastern Uganda:.an opportunity to improve newborn survival. PLoS One (2013) 1.05
Exploring SWAp's contribution to the efficient allocation and use of resources in the health sector in Zambia. Health Policy Plan (2008) 1.04
Changing Primary Care Doctors' Conceptions - A Qualitative Approach to Evaluating an Intervention. Adv Health Sci Educ Theory Pract (1997) 1.04
Challenges to ART scale-up in a rural district in Tanzania: stigma and distrust among Tanzanian health care workers, people living with HIV and community members. Trop Med Int Health (2010) 1.01
Low uptake of HIV testing during antenatal care: a population-based study from eastern Uganda. AIDS (2009) 1.01
Low validity of caretakers' reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda. Trans R Soc Trop Med Hyg (2008) 1.00
Knowledge and perceptions of drug quality among drug sellers and consumers in Lao PDR. Health Policy Plan (2004) 0.99
Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care. J Antimicrob Chemother (2004) 0.99
Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother (2003) 0.99
Community health workers - a resource for identification and referral of sick newborns in rural Uganda. Trop Med Int Health (2013) 0.96
Stakeholder perceptions of aid coordination implementation in the Zambian health sector. Health Policy (2009) 0.96
Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother (2011) 0.95
Leadership behaviour of nurse managers in relation to job satisfaction and work climate. J Nurs Manag (2008) 0.95
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. J Antimicrob Chemother (2006) 0.95
"I never had the money for blood testing" - caretakers' experiences of care-seeking for fatal childhood fevers in rural Uganda - a mixed methods study. BMC Int Health Hum Rights (2008) 0.94
Health systems research in Lao PDR: capacity development for getting research into policy and practice. Health Res Policy Syst (2007) 0.94
Posaconazole in human serum: a greater pharmacodynamic effect than predicted by the non-protein-bound serum concentration. Antimicrob Agents Chemother (2011) 0.94
Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models. Antimicrob Agents Chemother (2003) 0.94
Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob Agents Chemother (2011) 0.93
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother (2013) 0.93
Weekly antibiotic prescribing and influenza activity in Sweden: a study throughout five influenza seasons. Scand J Infect Dis (2003) 0.93
The Paris Declaration in practice: challenges of health sector aid coordination at the district level in Zambia. Health Res Policy Syst (2009) 0.93
"Practical knowledge" and perceptions of antibiotics and antibiotic resistance among drugsellers in Tanzanian private drugstores. BMC Infect Dis (2010) 0.93
The global need for effective antibiotics-moving towards concerted action. Drug Resist Updat (2011) 0.92
The role of the pharmacist-voices from nine African countries. Pharm World Sci (2007) 0.92
Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model. Antimicrob Agents Chemother (2007) 0.91
Alcohol-based hand-disinfection reduced children's absence from Swedish day care centers. Acta Paediatr (2008) 0.91
Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli. Antimicrob Agents Chemother (2005) 0.90
Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrob Agents Chemother (2003) 0.90
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria. Clin Microbiol Infect (1997) 0.89
Raman spectroscopic studies of the phase transitions in hexane at high pressure. Appl Spectrosc (2005) 0.89
Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agents Chemother (2010) 0.88
Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother (2012) 0.88
Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya--a quasi-experimental study using time series analysis. BMC Health Serv Res (2013) 0.88
High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis (2004) 0.87
Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Lancet Infect Dis (2011) 0.87
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother (2011) 0.87
Prescription of antibiotic agents in Swedish intensive care units is empiric and precise. Scand J Infect Dis (2007) 0.87
The global need for effective antibiotics-a summary of plenary presentations. Drug Resist Updat (2011) 0.86
Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002. J Antimicrob Chemother (2005) 0.85
Access, excess, and ethics--towards a sustainable distribution model for antibiotics. Ups J Med Sci (2014) 0.85
A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function. Br J Clin Pharmacol (2006) 0.85
Access to health care in relation to socioeconomic status in the Amazonian area of Peru. Int J Equity Health (2009) 0.85